Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells
Nature Medicine1996Vol. 2(5), pp. 574–577
Citations Over TimeTop 1% of 1996 papers
Related Papers
- → Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation(1995)1,524 cited
- → Protein Kinase C Inhibits CD95 (Fas/APO-1)-Mediated Apoptosis by at Least Two Different Mechanisms in Jurkat T Cells(1999)65 cited
- → Analysis of the Ligand Binding Site in Fas (CD95) by Site-Directed Mutagenesis and Comparison with TNFR and CD40(1998)20 cited
- FAS AND FASL EXPRESSION IN MAMMARY CARCINOMAS(2004)
- The biological role of FasL expressing Hep G2 cells(2004)